IDEXX LABORATORIES INC /DE is 29.3x more valuable than Anbio Biotechnology by market capitalization ($43.93 B vs $1.50 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NNNN | IDXX |
|---|---|---|
| Market cap | $1.50 B | $43.93 B |
| US-listed rank | #2315 | #351 |
| Revenue (latest FY) | $8.65M | $4.30B |
| Net income (latest FY) | $6.40M | $1.06B |
| Net margin | 74.1% | 24.6% |
| P/E (trailing FY) | 234.2 | 41.5 |
| SEC filings | 40 | 2,148 |
IDEXX LABORATORIES INC /DE is 29.3x more valuable than Anbio Biotechnology by market capitalization ($43.93 B vs $1.50 B).
In their latest fiscal years, Anbio Biotechnology reported $8.65M in revenue while IDEXX LABORATORIES INC /DE reported $4.30B.
Full pages: Anbio Biotechnology and IDEXX LABORATORIES INC /DE, or browse the full rankings.